ECRON ACUNOVA A/S: Financial statements 2013
CVR: 10132029
Source: annual report 2013, Danish Business Authority
01/04/2012 – 31/03/2013
ECRON ACUNOVA A/S (CVR 10132029) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 11,539,512 and a net result of DKK -2,511,684. Equity in the 2013 report amounted to DKK 3,173,390. The solvency ratio was 64.1%.
- Gross Profit
- DKK 11,539,512
- Profit/Loss
- DKK -2,511,684
- Equity
- DKK 3,173,390
- Total Assets
- DKK 4,951,680
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of August 23, 2013, REVISIONSFIRMAET MBP ApS, REGISTRERET REVISOR has been appointed auditor of ECRON ACUNOVA A/S.
As of August 23, 2013, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of ECRON ACUNOVA A/S.
About ECRON ACUNOVA A/S
ECRON ACUNOVA A/S was a Danish company of the type Aktieselskab based in København K, founded in 2003. The company has been dissolved on 3 February 2022. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Navitas Life Sciences A/S and ACRONORDIC A/S. The company has 4 employees (2020). In 2019, the company reported a gross profit of DKK 3,746,121 and a net result of DKK -1,900,826 compared with DKK -3,186,181 the year before. Equity in the 2019 report amounted to DKK -4,321,670.